email   Email Us: phone   Call Us: +1 (914) 407-6109   57 West 57th Street, 3rd floor, New York - NY 10019, USA

Lupine Publishers Group

Lupine Publishers

  Submit Manuscript

ISSN: 2641-1644

Open Access Journal of Reproductive System and Sexual Disorders

Review Article(ISSN: 2641-1644)

Sleep Disorders in Perimenopausal Women and Metabolic Syndrome, is that True?

Volume 1 - Issue 2

Pilnik Susana*, Belardo Maria Alejandra, Cavanna Malena, De Nardo Barbara and Starvaggi Agustina

  • Author Information Open or Close
    • Department of Gynecology, Italiano de Buenos Aires Hospital, Argentina

    *Corresponding author: Pilnik Susana, Department of Gynecology, Italiano de Buenos Aires Hospital, Argentina

Received: June 22, 2018;   Published: July 02, 2018

DOI: 10.32474/OAJRSD.2018.01.000109

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF


Sleep disorders (SD) are a common complaint in women going through menopause transition. It is well known that there is a close relationship between SD and one of the main menopausal symptoms: vasomotor symptoms (VMS). To acknowledge this association is essential when investigating menopausal transition and SD. The Study of Women’s Health across the Nation (SWAN), shows that the prevalence of sleep disturbance increases with age. The prevalence in perimenopausal and postmenopausal women varies from 39% to 47% and 35% to 60% respectively. Although both menopausal transition and aging increase sleep disturbances, etiology in menopausal women is probably multifactorial. A decline in the levels of reproductive hormones and melatonin, and the complex interaction among these hormones can significantly contribute to sleep problems, poor concentration, fatigue and decreased quality of life. On the one hand menopause nearly adversely affects all components of metabolic syndrome (MS) and on the other hand the cumulative long-term effects of deprived sleep have been associated with many cardio metabolic consequences including hypertension, obesity, and impaired glucose metabolism. Management strategies should be taken into account to help women ameliorate their night sleep, in order to prevent future complications and to improve their quality of life (QoL).

Keywords: Sleep disorders; Menopause; Vasomotor symptoms; Metabolic syndrome

Abbreviations: SD: Sleep Disorders; VMS: Vasomotor Symptoms; SWAN: Study of Women’s Health Across the Nation; MS: Metabolic Syndrome; QoL: Quality of Life; OSA: Obstructive Sleep Apnea; FSH: Follicle Stimulating Hormone; IR: Insulin Resistance; DBT: Type- 2 Diabetes; CVD: Cardio Vascular Disease; HPA: Hypothalamus-Pituitary-Adrenal; AHI: Apnea Hypopnea Index; GABA: Gamma- Amino Butyric Acid;

Abstract| Introduction| Treatment| Conclusion| References|